U.S. Retail Distributors Stock News

Turning Point Brands (NYSE:TPB) is accelerating its move toward nicotine pouches, with strong Modern Oral segment growth and heavier investment in new products. The company is rolling out its ALP nicotine pouch brand into physical retail stores while expanding distribution and marketing around Modern Oral offerings. Management is adjusting its product mix and messaging in response to higher tariffs and possible regulatory changes affecting its traditional portfolio. For you as an investor,...

StoneCo (STNE) is back in focus after reporting Q4 and full year 2025 results that shifted from heavy losses to profits, along with a clearer focus on payments, banking, and credit in Brazil. See our latest analysis for StoneCo. Despite a 4.08% 1 day share price return after the earnings release, StoneCo’s recent momentum has cooled. The 30 day and 90 day share price returns show declines of 15.62% and 9.15%, while the 1 year total shareholder return of 53.99% and 3 year total shareholder...

If you are wondering whether Taiwan Semiconductor Manufacturing is still fairly priced after its strong run, this article will walk through what the current share price might imply about value. The stock closed at US$357.44, with a 7 day return of a 7.8% decline, a 30 day return of 4.7%, an 11.8% return year to date, a 96.0% return over 1 year, and a 3 year return that is very large at 308.2%, while the 5 year return sits at 235.3%. Recent coverage has focused on Taiwan Semiconductor...

Coca-Cola FEMSA (NYSE:KOF) has reported the strongest monthly volume in its history, supported by solid full year growth in South America. The company is adjusting to a new excise tax in Mexico that is expected to affect future volumes. Management is rolling out digital tools, including Juntos+ Advisor, to improve efficiency and commercial execution. Coca-Cola FEMSA, listed on the NYSE under ticker KOF, is drawing attention after this record month, with its South American operations playing...

Assurant expanded its exclusive docuPAD eContracting dealership training program to the Atlanta market. The program focuses on legal, ethical, and sales best practices for F&I managers using vehicle protection products. This move increases access to Assurant’s proprietary automotive training for a wider group of dealership professionals. Assurant (NYSE:AIZ), trading at around $231.95, is adding fresh momentum to its automotive services footprint with this Atlanta rollout of its docuPAD...

Ford Motor (F) is back in focus after announcing a multimillion vehicle U.S. recall tied to braking, lighting, and trailer safety software, a substantial event that is weighing on investor sentiment. See our latest analysis for Ford Motor. The recall headlines come after a sharp 11.2% 7 day share price decline and a 7.2% 30 day share price return. However, Ford’s 1 year total shareholder return of 39.6% still points to earlier momentum that has recently cooled. If Ford’s recall has you...

ImmunityBio (NasdaqGS:IBRX) reports new regulatory approvals for its immunotherapy ANKTIVA in Europe and Saudi Arabia, expanding the drug's global reach. The company secures major distribution partnerships in both regions to support commercialization of ANKTIVA. A pivotal Phase 2 trial of ANKTIVA in BCG naïve non muscle invasive bladder cancer is completed ahead of schedule, with statistically significant superior results versus standard of care. ImmunityBio focuses on immunotherapies...

Analyst upgrade and accounting review set the stage ICON (ICLR) is back in focus after Jefferies shifted its rating from Hold to Buy, even as an internal accounting investigation continues and TD Cowen flagged only minor potential financial adjustments. See our latest analysis for ICON. Jefferies' upgrade and TD Cowen's relatively calm view on the accounting review arrive after a sharp reset, with a 30 day share price return of 38.29% decline and a 1 year total shareholder return of 40.91%...

Why Omega Healthcare Investors is on income investors’ radar Omega Healthcare Investors (OHI) has drawn attention after a solid month for the stock, with a roughly 10% return, prompting investors to reassess how its healthcare focused REIT model fits into an income portfolio. See our latest analysis for Omega Healthcare Investors. While the latest share price of $47.38 comes after a roughly 10% 1 month share price return and a 3.2% 3 month share price return, the 1 year total shareholder...

If you are wondering whether Wingstop's current share price lines up with its underlying value, you are not alone. That is exactly what this article is going to unpack. After a long term return of 106.9% over 5 years, the stock has recently cooled, with a 5.8% decline over 7 days, a 10.2% decline over 30 days, and a 6.8% decline year to date, while the 1 year return sits at 4.2%. These moves have prompted investors to reassess how much they are willing to pay for future growth and what risks...

Why Cintas Stock Is On Investors’ Radar Cintas (CTAS) has drawn attention after a period where the shares moved roughly 5% over the past month and about 7% over the past 3 months, prompting investors to reassess its recent performance. See our latest analysis for Cintas. Stepping back, Cintas has seen a 4.9% 1 month share price return and a 7.2% 3 month share price return. The 3 year total shareholder return of 89.2% and 5 year total shareholder return of 132.8% highlight how longer term...

Flowers Foods (FLO) is drawing fresh attention after several leadership changes, including a new president at its Simple Mills unit and planned board retirements, which coincide with an upcoming Q4 2026 earnings release. See our latest analysis for Flowers Foods. The leadership changes and upcoming Q4 2026 results are playing out against a weak price backdrop, with a 30 day share price return of 19.64% decline and a 1 year total shareholder return of 48.25% decline. This suggests momentum has...

If you are wondering whether Northrop Grumman's share price still makes sense at current levels, this article walks through what that price could imply about value. The stock last closed at US$753.84, with returns of 7.1% over 7 days, 10.0% over 30 days, 28.7% year to date, 61.5% over 1 year, 70.3% over 3 years and 172.4% over 5 years. Recent headlines around Northrop Grumman have centered on its role as a major U.S. defense contractor and a key player in large government programs. This...

A North Dakota court has finalized a $345 million judgment in favor of Energy Transfer related to litigation against Greenpeace over Dakota Access pipeline protests. The ruling follows years of legal disputes surrounding the pipeline project, and Greenpeace has said it plans to contest the decision. The judgment raises questions about how pipeline operators and environmental groups handle conflict around large infrastructure projects. For investors watching Energy Transfer (NYSE:ET), the...

Sea (SE) is back in focus after reporting fourth quarter and full year 2025 results that beat revenue expectations but missed earnings estimates, triggering a sharp share price reaction and fresh questions about costs. See our latest analysis for Sea. That earnings miss and cautious commentary have hit sentiment hard, with Sea’s 30 day share price return of 22.3% and year to date share price return of 32.9% both firmly negative. At the same time, the 1 year total shareholder return of 39.7%...

Why Intuitive Surgical’s latest quarter matters for investors Intuitive Surgical (ISRG) just reported a fiscal quarter with earnings and revenue above expectations, including 18.8% year over year revenue growth, putting fresh attention on the stock’s mix of systems, services, and software. That beat comes alongside several business updates that are shaping how investors think about the company, from the da Vinci 5 rollout and new cardiac procedure clearances to expanding European distribution...

Toll Brothers announced several new luxury home communities across the US, including openings in Pennsylvania and Washington. The company is preparing a highly anticipated launch in Texas that expands its presence in a key housing market. New offerings include active adult and energy efficient communities, along with final home opportunities in established neighborhoods. For investors watching NYSE:TOL, these community launches come as the stock trades around $153.56, with a 1-year return...

Workiva (NYSE:WK) reported quarterly results that surpassed its own revenue and EPS guidance. The company highlighted strong annual recurring revenue growth across its cloud-based platform. Management pointed to evidence of sustainable profitability and improved operating leverage in the period. Workiva runs a cloud platform that helps companies manage complex reporting, compliance, and data workflows across finance, risk, and ESG. These latest results come as more enterprises look for...

NIO Inc. reported that in February 2026 it delivered 20,797 vehicles, a 57.6% year-over-year increase, taking cumulative deliveries to 1.05 million and underlining rising contributions from its NIO, ONVO, and FIREFLY brands. The company also surpassed 100 million cumulative battery swaps and attracted over RMB 2.26 billion of new capital into its intelligent-driving chip unit, underscoring efforts to deepen its energy ecosystem and in-house technology capabilities. With February’s strong...

Innovative Industrial Properties (IIPR) has drawn fresh attention after recent share price moves, with gains over the past month and the past 3 months prompting investors to reassess its real estate investment trust profile. See our latest analysis for Innovative Industrial Properties. At a latest share price of $56.66, the 1 month share price return of 17.43% and 3 month share price return of 11.38% sit against a 1 year total shareholder return decline of 10.19%. This suggests recent...

How Tennant’s Recent Share Performance Frames the Investment Question Tennant (TNC) has seen its share price under pressure, with a roughly 20% decline over the past month and a weaker past 3 months. This has put recent performance firmly on investors’ radar. See our latest analysis for Tennant. That recent 20% slide over 30 days sits against a 15.04% year to date share price decline and a 23.04% 1 year total shareholder return loss. This suggests momentum has faded as investors reassess...

Viatris (NasdaqGS:VTRS) has had its supplemental New Drug Application for MR-141 (phentolamine ophthalmic solution 0.75%) accepted for FDA review to treat presbyopia. The filing seeks to expand indications within Viatris' ophthalmic franchise, targeting an age related vision condition that affects a broad patient group. FDA acceptance indicates the application has passed an initial completeness check and that regulators will now formally evaluate the submitted data package. For investors...

In late February and early March 2026, Celldex Therapeutics reported new positive Phase 2 data and open-label extension results for barzolvolimab in chronic spontaneous and inducible urticaria at the AAAAI Annual Meeting, alongside updated full-year 2025 financials showing revenue of US$1.55 million and a net loss of US$258.76 million. The latest findings showing high rates of repeated complete or partial responses after retreatment underscore barzolvolimab’s potential to address...

Dividend increase and earnings miss set the stage for Waste Management Waste Management (WM) has lifted its quarterly dividend to $0.945 per share, payable on March 27, 2026, even as its Q4 earnings miss has put fresh focus on how investors price the stock. This combination of a higher cash return and a weaker earnings print gives you two immediate questions to think about: how sustainable the new payout might be, and whether recent price moves already reflect the earnings disappointment. See...